1 |
Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev 2017;3:7-11.
DOI
|
2 |
Le T, Chong J. Cardiac progenitor cells for heart repair. Cell Death Discov 2016;2:16052.
DOI
|
3 |
Noor N, Patel CB, Rockman HA. -arrestin: a signaling molecule and potential therapeutic target for heart failure. J Mol Cell Cardiol 2011;51:534-41.
DOI
|
4 |
Wurth R, Bajetto A, Harrison JK, Barbieri F, Florio T. CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment. Front Cell Neurosci 2014;8:144.
|
5 |
Nakaya M, Chikura S, Watari K, et al. Induction of cardiac fibrosis by -blocker in G protein-independent and G protein-coupled receptor kinase 5/ -arrestin2-dependent signaling pathways. J Biol Chem 2012;287:35669-77.
DOI
|
6 |
Bathgate-Siryk A, Dabul S, Pandya K, et al. Negative impact of -arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms. Hypertension 2014;63:404-12.
DOI
|
7 |
Seo SK, Kim N, Lee JH, et al. -arrestin2 affects cardiac progenitor cell survival through cell mobility and tube formation in severe hypoxia. Korean Circ J 2018;48:296-309.
DOI
|
8 |
McCrink KA, Maning J, Vu A, et al. -arrestin2 improves post-myocardial infarction heart failure via sarco(endo)plasmic reticulum Ca(2+)-ATPase-dependent positive inotropy in cardiomyocytes. Hypertension 2017;70:972-81.
DOI
|
9 |
Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011;378:1847-57.
DOI
|
10 |
Hu S, Wang D, Wu J, et al. Involvement of -arrestins in cancer progression. Mol Biol Rep 2013;40:1065-71.
DOI
|